Literature DB >> 11129182

Cellular signaling by tyrosine phosphorylation in keloid and normal human dermal fibroblasts.

G S Chin1, W Liu, D Steinbrech, M Hsu, H Levinson, M T Longaker.   

Abstract

Keloids represent a dysregulated response to cutaneous wounding that results in disfiguring scars. Unique to humans, keloids are characterized by an accumulation of extracellular matrix components. The underlying molecular mechanisms of keloid pathogenesis, however, remain largely uncharacterized. Similarly, cellular signaling mechanisms, which may indicate inherent differences in the way keloid fibroblasts and normal human dermal fibroblasts interact with extracellular matrix or other cells, have not been investigated. As part of a fundamental assessment of cellular response to injury in keloid fibroblasts, phosphorylation studies were performed using three different keloid (n = 3) and normal human dermal (n = 3) fibroblast cell lines. These studies were undertaken to elucidate whether keloid and normal human dermal fibroblasts exhibit different tyrosine kinase activity. Initially, distinct tyrosine phosphorylation patterns of keloid and normal human dermal fibroblasts were demonstrated. Next, the phosphorylation patterns were correlated with known molecules that may be important to keloid pathogenesis. On the basis of molecular weight, it was hypothesized that the highly phosphorylated bands seen in keloid fibroblasts represented epidermal growth factor receptor (EGFR); discoidin domain receptor 1 (DDR1); and Shc, an adaptor protein known to bind many tyrosine kinases, including EGFR and DDR1. Individual immunoblotting using EGFR, DDR1, and Shc antibodies revealed greater expression in keloid fibroblasts compared with normal human dermal fibroblasts. These data substantiate for the first time the finding of greater phosphorylation by the above-mentioned molecules, which may be important in keloid pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129182     DOI: 10.1097/00006534-200012000-00014

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  11 in total

1.  Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures.

Authors:  Tai-Lan Tuan; Huayang Wu; Eunice Y Huang; Sheree S N Chong; Walter Laug; Diana Messadi; Paul Kelly; Anh Le
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 2.  Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid.

Authors:  Yijun Xia; Youbin Wang; Mengjie Shan; Yan Hao; Hao Liu; Qiao Chen; Zhengyun Liang
Journal:  Burns Trauma       Date:  2022-06-25

3.  Plasma and cellular fibronectin: distinct and independent functions during tissue repair.

Authors:  Wing S To; Kim S Midwood
Journal:  Fibrogenesis Tissue Repair       Date:  2011-09-16

Review 4.  Dietary Management of Skin Health: The Role of Genistein.

Authors:  Natasha Irrera; Gabriele Pizzino; Rosario D'Anna; Mario Vaccaro; Vincenzo Arcoraci; Francesco Squadrito; Domenica Altavilla; Alessandra Bitto
Journal:  Nutrients       Date:  2017-06-17       Impact factor: 5.717

Review 5.  Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies.

Authors:  Silvian Tan; Nonhlanhla Khumalo; Ardeshir Bayat
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

6.  Dermal fibroblasts derived from fetal and postnatal humans exhibit distinct responses to insulin like growth factors.

Authors:  Kerstin J Rolfe; Alison D Cambrey; Janette Richardson; Laurie M Irvine; Adriaan O Grobbelaar; Claire Linge
Journal:  BMC Dev Biol       Date:  2007-11-07       Impact factor: 1.978

7.  Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1.

Authors:  Constantin C Chipev; Marcia Simon
Journal:  BMC Dermatol       Date:  2002-11-21

8.  The JAK2/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro.

Authors:  Ying Zhou; Yuexin Sun; Wenjun Hou; Liwen Ma; Yue Tao; Dan Li; Cui Xu; Jun Bao; Weixin Fan
Journal:  Int J Mol Med       Date:  2020-04-29       Impact factor: 4.101

Review 9.  Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances.

Authors:  Hardeep Singh Tuli; Muobarak Jaber Tuorkey; Falak Thakral; Katrin Sak; Manoj Kumar; Anil Kumar Sharma; Uttam Sharma; Aklank Jain; Vaishali Aggarwal; Anupam Bishayee
Journal:  Front Pharmacol       Date:  2019-12-06       Impact factor: 5.810

10.  Silencing of sinusoidal DDR1 reduces murine liver metastasis by colon carcinoma.

Authors:  Irene Romayor; Iker Badiola; Aitor Benedicto; Joana Márquez; Alba Herrero; Beatriz Arteta; Elvira Olaso
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.